Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

INVO Fertility (IVF) Net Income towards Common Stockholders (2016 - 2025)

INVO Fertility (IVF) has disclosed Net Income towards Common Stockholders for 15 consecutive years, with -$2.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Net Income towards Common Stockholders fell 62.18% to -$2.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$11.2 million, a 50.26% decrease, with the full-year FY2024 number at -$9.3 million, down 16.33% from a year prior.
  • Net Income towards Common Stockholders was -$2.6 million for Q3 2025 at INVO Fertility, down from $12.7 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $12.7 million in Q2 2025 to a low of -$17.4 million in Q1 2025.
  • A 5-year average of -$2.2 million and a median of -$2.2 million in 2024 define the central range for Net Income towards Common Stockholders.
  • Peak YoY movement for Net Income towards Common Stockholders: plummeted 2816.08% in 2022, then skyrocketed 665.76% in 2025.
  • INVO Fertility's Net Income towards Common Stockholders stood at $101782.0 in 2021, then tumbled by 2816.08% to -$2.8 million in 2022, then rose by 27.84% to -$2.0 million in 2023, then crashed by 94.21% to -$3.9 million in 2024, then surged by 31.74% to -$2.6 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's Net Income towards Common Stockholders are -$2.6 million (Q3 2025), $12.7 million (Q2 2025), and -$17.4 million (Q1 2025).